Toll Biotech Co. Ltd. (Beijing)
Toll Biotech Co. Ltd. (Beijing)
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis | Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, connective tissue disorder, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis | Recruiting | Phase 2 | 2026-10-01 | NCT07408024 | |
| A Phase II Study of TollB-001 Tablets in Systemic Sclerosis | Skin and Connective Tissue Diseases, connective tissue disorder, skin disorder, systemic sclerosis | Not yet recruiting | Phase 2 | 2026-08-04 | NCT07745725 |